BROLENE

This brand name is authorized in Estonia, Ireland, New Zealand, UK.

Active ingredients

The drug BROLENE contains one active pharmaceutical ingredient (API):

1	Propamidine UNII G20G12V769 - PROPAMIDINE
	Propamidine is a member of the aromatic diamidine group of compounds which possess bacteriostatic properties against a wide range of organisms. These diamidines exert antibacterial action against pyrogenic cocci, antibiotic resistant staphylococci and some Gram-negative bacilli, the activity of the diamidines being retained in the presence of organic matter such as tissue fluids, pus and serum.
	Read more about Propamidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BROLENE Eye drops	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AX14	Dibrompropamidine	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AX Other antiinfectives
Discover more medicines within S01AX14
S01AX15	Propamidine	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AX Other antiinfectives
Discover more medicines within S01AX15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1105704, 1728727
GB	Medicines & Healthcare Products Regulatory Agency	38997
NZ	Medicines and Medical Devices Safety Authority	573